Pharmaceutical Manufacturing – Levofloxacin Tablets (500mg)

This contract involves the subcontracted manufacture of Levofloxacin tablets, each containing 500 mg of the active ingredient, packaged in bottles of 50 tablets. The production must comply with FDA regulations, current Good Manufacturing Practices (cGMP), and Defense Logistics Agency (DLA) technical specifications. The tablets are required to have a minimum shelf life of 24 months, ensuring long-term stability and efficacy. The contract is issued by the Department of Defense through the Medical Supply Chain Pharmaceutical Federal Supply Agency, with the place of performance specified as Fort Stewart. The solicitation was posted on May 28, 2026, and responses are due by June 3, 2026. The manufacturing effort falls under the NAICS code 325412, which covers pharmaceutical preparation manufacturing. This subcontract reflects the government's need to secure a reliable source for quality-controlled antibiotic tablets in support of medical supply requirements.